Hyperfine (HYPR) EBT (2021 - 2026)

Hyperfine (HYPR) has reported EBT for 6 consecutive years, with -$9.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT fell 0.79% year-over-year to -$9.3 million; the trailing twelve-month figure through Jun 2026 stood at -$34.9 million (up 11.45% YoY), and the FY2025 full-year result was -$35.6 million, up 12.64% from the prior year.
• EBT eased to -$9.3 million in Q2 2026 per HYPR's latest filing, from -$8.6 million in the prior quarter.
• Across five years, EBT topped out at -$5.9 million in Q4 2025 and bottomed at -$23.8 million in Q1 2022.
• Historically, EBT has averaged -$11.8 million across 5 years, with a median of -$10.5 million in 2023.
• The sharpest annual moves came in 2022 and 2023: EBT slumped 205.04% in 2022, then soared 54.07% in 2023.
• Over 5 years, EBT stood at -$13.1 million in 2022, then climbed by 18.19% to -$10.7 million in 2023, then advanced by 2.75% to -$10.4 million in 2024, then jumped by 43.1% to -$5.9 million in 2025, then plunged by 57.27% to -$9.3 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$9.3 million, -$8.6 million, and -$5.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.